This preview has intentionally blurred sections. Sign up to view the full version.View Full Document
Unformatted text preview: results of a general financial analysis. The financial study will aid the investor – whether he be a risk averter or a risk taker- in the decision of the pre-FDA research length and the intensity. Although the development of a new drug is of high risk and uncertainty, as shown in this paper, it is certain that a successful drug would have great benefit to humans due to its wide-spread effect. There are many diseases- malaria, HIV, cancer, leishmaniasis, and tuberculosis, to name a few- that are currently responsible for the deaths of millions of people per year around the world, and steps are being taken to counter their negative effects. Using the risk modeled in this paper, the investor is responsible for weighing the technical and financial risks of the project against the potential for revolutionary change world-wide....
View Full Document
- Spring '10
- Chemical Engineering, Melissa Martin, new drug, Erica Clemente- Harl, Dr. Miguel Bagajewicz